The global cardiopulmonary stress testing systems market is growing efficiently, expected to grow at a CAGR of 4.8%. Globally, growing diagnostic procedures for cardiovascular-related disorders such as heart valve imbalance and arrhythmia will drive market growth. Increasing awareness about new lifestyle diseases along with heart and lung disorders are factors driving the overall growth of cardiopulmonary stress testing systems market globally. Other major factors include development in the portable device industry, invention of high sensitivity ECG devices, growth in the cardiovascular centers for enhanced diagnostics and new technology expansion in the emerging nations at low cost.

The blood and bone marrow cancer treatment market is set to reach from US$ 38.8 Bn in 2018 to US$ 74.9 Bn by 2027 at a compound annual growth rate (CAGR) of 7.7% during the forecast period from 2019 to 2027. As per the research findings brought forward by Janssen Pharmaceutica N.V. approximately 900,000 people throughout the globe are diagnosed with blood cancer annually, it holds a share of 7% of all types of known cancer.

Alpha thalassemia treatment market accounted for a market value of US$ 526.1 Mn in 2018 and projected to grow at a CAGR of 7.1% during the forecast period from 2019 to 2027. Alpha thalassemia is a congenital autosomal recessive disorder caused due to absence or reduction in alpha globin peptides due to a deletion or mutation of the alpha globin genes. Alpha thalassemia usually found in Africa, the Middle East, India, Southeast Asia, southern China, and the Mediterranean region.

Gene synthesis offers solutions in synthetic biology for creating artificial genes in vitro with the help of solid phase DNA synthesis. Global gene synthesis market is expected to rise with a CAGR of 17.4% during the forecast year 2019-2026. Significant decrease in the cost of gene synthesis has promoted the demand in drug development, research activities, therapies, diagnostics etc. and has thus fuelled immense growth in the market.

Behavioral health refers to ways of promoting well-being by intervening or preventing mental illnesses such as anxiety or depression. It also aims to intervene or prevent in substance abuse or other addictions. The global behavioral/ mental health software market is expected to have a CAGR of about 15% during the forecast period 2019-2026. Factors driving the market growth are high government funding, growing electronic health records adoption in hospitals and high demand for mental health services.

The global sterilization cases and trays market is anticipated to grow with a CAGR of around 6% during the forecast period (2019-2026). Sterilization are processes employed to remove all viable life forms comprises of prions, bacteria, fungi, viruses and spore forms from surfaces of equipment, medications, food ingredients, pharmaceuticals, and biological culture medium.

Irinotecan is an antineoplastic enzyme inhibitor that primarily finds application in the treatment of Cancer especially colorectal cancer.  The global Irinotecan demand  is primarily driven due to increasing incidences of colorectal cancer globally coupled with increasing research and development on biological and targeted drug therapies for cancer and increasing research and development of novel approaches to cancer treatment.

Disposable medical supplies comprise of medical devices or consumables, medical apparatus that are proposed for temporary or one time use in medical settings. These supplies are a vital component in healthcare settings, as it helps to reduce healthcare-associated costs and save staff time. Some of the examples of disposables medical supplies contain drug tests disposables, bandages & wraps, exam gowns, gloves, suction catheters, face masks, hypodermic needles, syringes, surgical sponges, and others. The global disposable medical supplies market is anticipated to grow at CAGR of around 7 % during the forecast period (2019 to 2026).

Cancer drugs are theurapeutics based treatment procedures that help to treat cancer. The global cancer drug demand  is primarily driven due to increasing incidences of cancer globally coupled with increasing research and development on biological and targeted drug therapies for cancer and increasing research and development of novel approaches to cancer treatment.  Global cancer drug market is expected to grow with a CAGR of 7% over the forecast period of 2019 to 2026.

The global robotic prosthetic market is estimated to grow with a CAGR of around 10.1% during 2019-2026. Rising number of amputation cases because of numerous risk factors such as cancerous tumors, accidents, severe injuries, etc., and increased technological advancements are major factors that are boosting growth in global market. Moreover, Supportive government initiatives also contributes towards the growth of global market. According to Bay Trust Radio, in 2018, Government of UK invested around $2 million (£1.5 million), the investment will allow access to prosthetics to around 2,000 disabled children. 

Brisk Insights has published a study titled “Treatment Resistant Depression Market Investigation: Market Size, Future Prospects, and Competitive Analysis, through 2025″, involves the global markets for Treatment Resistant Depression by segments, regional classification, profiling of major market players and competitive front for the period 2017 to 2025.

The global cervical cancer diagnostics market is expected to grow at the CAGR of 5% during 2016-2022. Cervical cancer happens in cells of the cervix due to abnormal cell growth. Continuous spread of human papillomavirus (HPV) infection mainly in the females, rising incidents of weak immune system, and frequent use of oral contraceptive pills are the main factors responsible for the growth of cervical cancer diagnostic tests market. Changes in life style such as smoking, and multiple sex partners having genetic cervical cancers are anticipated to drive the global market in the near future.

Medical tourism’ is defined as the term used for travelling of patients from their home country to different destinations for the sole purpose of treatment that may also include an extended holiday for rest and pleasure. Rising healthcare costs in developed countries along with the availability of high quality medical services available at lower prices in various developing nations has primarily propelled the expansion of the medical tourism industry, globally. Moreover, increasing elderly population coupled with growing number of uninsured population has further boosted the market growth. Nowadays, patients are travelling abroad not only to get cosmetic surgeries with a quick recovery, but also for more sophisticated cardiovascular surgeries.

The global analgesic infusion pumps market has been growing at an impressive rateduring the forecasted period of 2016-2022. Analgesic infusion pumps are the equipments used to inject analgesic drugs directly into patient’s body. Analgesic drugs ensure relief from chronic disorders, including failed back syndrome pain, hypertension, post-operative pain, myocardial ischemia, pneumonia, myocardial infarction and complex regional pain syndrome (CRPS).

The global smart fitness devices market has been expected to reach $9600 million in terms of revenue till 2022 at the growing CAGR of 26% during 2016-2022.Smart fitness devices market has beenanticipated to experience robust growth during the forecasted period due to rising awareness among the people pertaining to fitness, time saving portable and wearable devices, efficiency of the devices, and increasing healthcare disposable income.

The global healthcare mobility solutions market has been expected to grow at the CAGR of 30.6 % during 2016-2022 and it has been expected to reach $91147 million till 2022 in terms of revenue.Nowadays, mobility has evolved as a main technology in the healthcare sector, as it has helped the medical community to accept a patient centered approach, by decreasingthe healthcare expenses and the implications of deficiency of healthcare experts as well as of nursing.

The global care management solution market has been expected to grow at the CAGR of 17.8% market during 2016-2022. The global care management solutions market has been projected to reach $16 billion in terms of revenue by 2022 from $6.93 billion in 2016 .The major factors driving the market are high involvement of government and initiatives to promote patient-centric care, increasing geriatric population and cases of chronic diseases, care management solutions helps to reduce healthcare costs, increasing medical tourism sector, advancement in information technology, big data capabilities and so on. The rising geriatricpopulationis one of the key driver for the market.

The global vendor neutral archive (VNA) & PACS market has been expected to grow at the CAGR of 7.2 % during 2016-2022 and is expected to reach $5700 million in terms of revenue till 2022.The vendor neutral archives (VNAs) are information technology platforms that allow long-term, single, standard-based and centralized storage of medical imaging studies and other patient data from multiple vendor PACS. On the other hand, picture archiving and communication system function as tools that directly connect to different imaging modalities in a facility by obtaining images from them.

The global healthcare EDI market has been expected to grow at the CAGR of 12.7 % during 2016-2022 and is expected to reach $3150 million till 2022.Electronic Data Interchange (EDI), is an advanced electronic communication technology that offers exchange data standards, for exchange of data into any kind of electronic technology.The EDI or Electronic data exchange permits interchange of important data between two or more companies, situated in different countries, by application of assured standards of EDI.EDI can be defined as, exchange of data, by using encoded message terms and standards, from one computer device to another, without any human or mechanical interference.

The global healthcare analytical testing services market is expected to grow at the CAGR of 12.1 % during 2016-2022 and is expected to reach $4710 million till 2022. Growth in market is mainly driven by the rising demand for analytical services for large-molecule drugs and biologics, increasing acceptance of the quality by design approach in pharmaceutical manufacturing and rising demand from the nutraceutical industry, increasing outsourcing of analytical testing by pharmaceutical companies. Apart from that, enhanced quality standards in the pharmaceutical industry, rapid growth in the biologic biosimilar market and presence of a large pool of analytical testing companies are further expected to boost the growth of global healthcare analytical testing services market.